Skip navigation
Sidebar -

Advanced search options →

Welcome

Welcome to CEMB forum.
Please login or register. Did you miss your activation email?

Donations

Help keep the Forum going!
Click on Kitty to donate:

Kitty is lost

Recent Posts


New Britain
Today at 03:10 PM

German nationalist party ...
Today at 01:11 PM

Do humans have needed kno...
Yesterday at 03:13 PM

Lights on the way
by akay
February 05, 2025, 10:04 PM

Gaza assault
February 05, 2025, 10:04 AM

AMRIKAAA Land of Free .....
February 03, 2025, 09:25 AM

The origins of Judaism
by zeca
February 02, 2025, 04:29 PM

Qur'anic studies today
by zeca
February 01, 2025, 11:48 PM

Random Islamic History Po...
by zeca
February 01, 2025, 07:29 PM

اضواء على الطريق ....... ...
by akay
February 01, 2025, 11:55 AM

News From Syria
by zeca
December 28, 2024, 12:29 AM

Mo Salah
December 26, 2024, 05:30 AM

Theme Changer

 Topic: Science and Origins of Ebola viruses

 (Read 5724 times)
  • 1« Previous thread | Next thread »
  • Science and Origins of Ebola viruses
     OP - October 08, 2014, 12:47 PM

    Science and Origins of Ebola viruses (Collected/reprinted from different sources..)

    Ebola virus disease (EVD), Ebola hemorrhagic fever (EHF), or simply Ebola is a disease of humans and other primates caused by an ebolavirus. Symptoms start two days to three weeks after contracting the virus, with a fever, sore throat, muscle pain, and headaches. Typically, vomiting, diarrhea, and rash follow, along with decreased function of the liver and kidneys. Around this time, affected people may begin to bleed both within the body and externally.

    The virus may be acquired upon contact with blood or bodily fluids of an infected human or other animal. Spreading through the air has not been documented in the natural environment. Fruit bats are believed to be a carrier and may spread the virus without being affected. Once human infection occurs, the disease may spread between people, as well. Male survivors may be able to transmit the disease via semen for nearly two months. To make the diagnosis, typically other diseases with similar symptoms such as malaria, cholera and other viral hemorrhagic fevers are first excluded. To confirm the diagnosis, blood samples are tested for viral antibodies, viral RNA, or the virus itself.


    Signs and Symptoms:



    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #1 - October 08, 2014, 12:48 PM

    Thanks!
  • Science and Origins of Ebola viruses
     Reply #2 - October 08, 2014, 12:57 PM

    Ebola is both rare and very deadly Virus. Since the first outbreak in 1976, Ebola viruses have infected thousands of people and killed about one-third of them. Symptoms can come on very quickly and kill fast:


    Piot (right), at the Institute of Tropical Medicine, Antwerp in 1976

    The  Ebola  virus detective who discovered Ebola in 1976:  

    Nearly 40 years ago, a young Belgian scientist travelled to a remote part of the Congolese rainforest - his task was to help find out why so many people were dying from an unknown and terrifying disease.

    Quote
    In September 1976, a package containing a shiny, blue thermos flask arrived at the Institute of Tropical Medicine in Antwerp, Belgium.  Working in the lab that day was Peter Piot, a 27-year-old scientist and medical school graduate training as a clinical microbiologist. "It was just a normal flask like any other you would use to keep coffee warm," recalls Piot, now Director of the London School of Hygiene and Tropical Medicine.



    Quote
    dr. Peter Piot, MD, PhD FRCP FMedSci (born 1949) is a Belgian microbiologist known for his research into Ebola and AIDS. After helping discover the Ebola virus in 1976 and leading efforts to contain the first-ever recorded Ebola epidemic that same year, Piot became a pioneering researcher into AIDS. He has held key positions in the United Nations and World Health Organization involving AIDS research. He has also served as a professor at several universities worldwide.


    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #3 - October 08, 2014, 01:05 PM

    Gosh those symptoms could fit any virus..  How deadly is it compared to swine flu, obviously worse, swine flu was airborne wanst it ?  my girls and i were unlucky to get that the last time, a kid at school went travelling and spread it around, was like being on hallucinogenic drugs..
  • Science and Origins of Ebola viruses
     Reply #4 - October 08, 2014, 01:17 PM

     EVD(Ebola virus disease) is caused by four of five viruses classified in the genus Ebolavirus, family Filoviridae, order Mononegavirales. The four disease-causing viruses are Bundibugyo virus (BDBV), Sudan virus (SUDV), Taï Forest virus (TAFV), and one called, simply, Ebola virus (EBOV, formerly Zaire Ebola virus)). Ebola virus is the sole member of the Zaire ebolavirus species and the most dangerous of the known Ebola disease-causing viruses, as well as being responsible for the largest number of outbreaks.[16] The fifth virus, Reston virus (RESTV), is not thought to be disease-causing in humans. These five viruses are closely related to the Marburg viruses.

    Transmission  and life cycles of EV




    Quote
    Human-to-human transmission can occur via direct contact with blood or bodily fluids from an infected person (including embalming of an infected dead person) or by contact with objects contaminated by the virus, particularly needles and syringes.  Other body fluids with ebola virus include saliva, mucus, vomit, feces, sweat, tears, breast milk, urine, and semen. Entry points include the nose, mouth, eyes, or open wounds, cuts and abrasions. The potential for widespread EVD infections is considered low as the disease is only spread by direct contact with the secretions from someone who is showing signs of infection.  The symptoms limit a person's ability to spread the disease as they are often too sick to travel.  Because dead bodies are still infectious, traditional burial rituals may spread the disease. Nearly two thirds of the cases of Ebola in Guinea during the 2014 outbreak are believed to be due to burial practices.  Semen may be infectious in survivors for up to 7 weeks. It is not entirely clear how an outbreak is initially started. The initial infection is believed to occur after ebola virus is transmitted to a human by contact with an infected animal's body fluids.

    One of the primary reasons for spread is that the health systems in the part of Africa where the disease occurs function poorly.   Medical workers who do not wear appropriate protective clothing may contract the disease.  Hospital-acquired transmission has occurred in African countries due to the reuse of needles and lack of universal precautions.  Some healthcare centers caring for people with the disease do not have running water


    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #5 - October 08, 2014, 03:17 PM

    Well let me put here this fascinating story of Ebola virus discovery by that 27 year old     Peter Piot medical school graduate training as a clinical microbiologist., 

    Quote
    In September 1976, a package containing a shiny, blue thermos flask arrived at the Institute of Tropical Medicine in Antwerp, Belgium. Working in the lab that day was Peter Piot, a 27-year-old scientist and medical school graduate training as a clinical microbiologist.

    "It was just a normal flask like any other you would use to keep coffee warm," recalls Piot, now Director of the London School of Hygiene and Tropical Medicine. But this thermos wasn't carrying coffee - inside was an altogether different cargo. Nestled amongst a few melting ice cubes were vials of blood along with a note.

    It was from a Belgian doctor based in what was then Zaire, now the Democratic Republic of Congo - his handwritten message explained that the blood was that of a nun, also from Belgium, who had fallen ill with a mysterious illness which he couldn't identify.

    This unusual delivery had travelled all the way from Zaire's capital city Kinshasa, on a commercial flight, in one of the passengers' hand luggage. "When we opened the thermos, we saw that one of the vials was broken and blood was mixing with the water from the melted ice," says Piot.

    He and his colleagues were unaware just how dangerous that was. As the blood leaked into the icy water so too did a deadly unknown virus. The samples were treated like numerous others the lab had tested before, but when the scientists placed some of the cells under an electron microscope they saw something they didn't expect. "We saw a gigantic worm like structure - gigantic by viral standards," says Piot. "It's a very unusual shape for a virus, only one other virus looked like that and that was the Marburg virus."

    The Marburg virus was first recognised in 1967 when 31 people became ill with haemorrhagic fever in the cities of Marburg and Frankfurt in Germany and in Belgrade, the capital of Yugoslavia. This Marburg outbreak was associated with laboratory staff who were working with infected monkeys imported from Uganda - seven people died.

    News had reached Antwerp that the nun, who was under the care of the doctor in Zaire, had died. The team also learnt that many others were falling ill with this mysterious illness in a remote area in the north of the country - their symptoms included fever, diarrhoea and vomiting followed by bleeding and eventually death.

    Two weeks later Piot, who had never been to Africa before, was on a flight to Kinshasa. "It was an overnight flight and I couldn't sleep. I was so excited about seeing Africa for the first time, about investigating this new virus and about stopping the epidemic."

    The journey didn't end in Kinshasa - the team had to travel to the centre of the outbreak, a village in the equatorial rainforest, about 1,000km (620 miles) further north. "The personal physician of President Mobutu, the leader of Zaire at that time, arranged a C-130 transport aircraft for us," recalls Piot. They loaded a Landrover, fuel and all the equipment they needed on to the plane.



    Piot (second from left) and the team in Yambuku in 1976


    Ebola virus 1976 Optical microscope image

    Quote
    When the C-130 landed in Bumba, a river port situated on the northernmost point of the Congo River, the fear surrounding the mysterious disease was tangible. Even the pilots didn't want to hang around for long - they kept the airplane's engines running as the team unloaded their kit.

    "As they left they shouted 'Adieu,'" says Piot. "In French, people say 'Au Revoir' to say 'See you again', but when they say 'Adieu' - well, that's like saying, 'We'll never see you again.'"

    Standing on the tarmac watching the plane leave, facing a deadly unknown virus in an unfamiliar place, some people might have regretted the decision to go there.

    "I wasn't scared. The excitement of discovery and wanting to stop the epidemic was driving everything. We heard far more people were dying from the disease than we originally thought and we wanted to get to work," Piot says. The curiosity and sense of adventure that brought Piot to this point had been ignited many years earlier when he was a young boy growing up in a small rural village in the Flanders region of Belgium.

    A museum near Piot's home was dedicated to a local saint who worked with leprosy patients, and it was here that he got his first glimpse into the world of disease and microbiology.

    "I decided one day to cycle to the museum. The old pictures I saw there of those suffering from leprosy fascinated me," he says. "That sparked my interest in medicine - it gave me a thirst for scientific knowledge, a desire to help people and I hoped it would give me a passport to the world."

    It did give Piot a passport to the world. The team's final destination was the village of Yambuku - about 120km (75 miles) from Bumba, where the plane had left them.

    Yambuku was home to an old Catholic mission - it had a hospital and a school run by a priest and nuns, all of them from Belgium.

    "The area was beautiful. The mission was surrounded by lush rainforest and the earth was red - the nature was incredibly rich but the people were so poor," says Piot. "Joseph Conrad called that place 'The Heart of Darkness', but I thought there was a lot of light there." The beauty of Yambuku belied the horror that was unfolding for the people that lived there.

    When Piot arrived, the first people he met were a group of nuns and a priest who had retreated to a guesthouse and established their own cordon sanitaire - a barrier used to prevent the spread of disease.

    There was a sign on the cord, written in the local Lingala language that read, "Please stop, anybody who crosses here may die."

    "They had already lost four of their colleagues to the disease," says Piot. "They were praying and waiting for death."

    Piot jumped over the cordon and told them that the team would help them and stop the epidemic. "When you are 27, you have all this confidence," he says.



    The nuns told the newly arrived scientists what had happened, they spoke about their colleagues and those in the village who had died and how they tried to help as best they could.

    Quote
    These were the three questions they asked:

    • How did the epidemic evolve? Knowing when each person caught the virus gave clues to what kind of infection this was - from here the story of the virus began to emerge.

    • Where did the infected people come from? The team visited all the surrounding villages and mapped out the number of infections - it was clear that the outbreak was closely related to areas served by the local hospital.

    • Who gets infected? The team found that more women than men caught the disease and particularly women between 18 and 30 years old - it turned out that many of the women in this age group were pregnant and many had attended an antenatal clinic at the hospital.

    The mystery of the virus was beginning to unravel.

    The team then discovered that the women who attended the antenatal clinic all received a routine injection. Each morning, just five syringes would be distributed, the needles would be reused and so the virus was spread between the patients.

    "That's how we began to figure it out," recalls Piot. "You do it by talking, looking at the statistics and using logical deduction." The team also noticed that people were getting ill after attending funerals. When someone dies from Ebola, the body is full of the virus - any direct contact, such as washing or preparation of the deceased without protection can be a serious risk.

    The next step was to stop the transmission of the virus.

    "We systematically went from village to village and if someone was ill they would be put into quarantine," says Piot. "We would also quarantine anyone in direct contact with those infected and we would ensure everyone knew how to correctly bury those who had died from the virus."

    The closure of the hospital, the use of quarantine and making sure the community had all the necessary information eventually brought an end to the epidemic - but nearly 300 people died.



    Many people were interviewed and detailed notes were taken during the investigation

    Quote
    The team also noticed that people were getting ill after attending funerals. When someone dies from Ebola, the body is full of the virus - any direct contact, such as washing or preparation of the deceased without protection can be a serious risk.

    The next step was to stop the transmission of the virus.

    "We systematically went from village to village and if someone was ill they would be put into quarantine," says Piot. "We would also quarantine anyone in direct contact with those infected and we would ensure everyone knew how to correctly bury those who had died from the virus."

    The closure of the hospital, the use of quarantine and making sure the community had all the necessary information eventually brought an end to the epidemic - but nearly 300 people died.

    Piot and his colleagues had learned a lot about the virus during three months in Yambuku, but it still lacked a name.

    "We didn't want to name it after the village, Yambuku, because it's so stigmatising. You don't want to be associated with that," says Piot.

    The team decided to name the virus after a river. They had a map of Zaire, although not a very detailed one, and the closest river they could see was the Ebola River. From that point on, the virus that arrived in a flask in Antwerp all those months earlier would be known as the Ebola virus.


    The Ebola River in 1976 In February 2014, Piot returned to Yambuku for only the second time since 1976, to mark his 65th birthday. He met Sukato Mandzomba, one of the few who caught the virus in 1976 and survived. "It was fantastic to meet him again, it was a very moving moment," says Piot.

    Back then, Mandzomba was a nurse in the local hospital and could speak French so the pair had managed to build up a rapport. "He's still living in Yambuku and still working in the hospital - he's now running the lab there and it's impeccable. I was really impressed," Piot says.


    Piot and Mandzomba in Yambuku, February 2014

    Quote
    It's 38 years since that initial outbreak and the world is now experiencing its worst Ebola epidemic ever. So far more than 600 people have died in the West African countries of Guinea, Liberia and Sierra Leone. The current situation has been called unprecedented, the spread of the disease across three countries making it more complicated to deal with than ever before.

    In the absence of any vaccine or cure, the advice for this outbreak is much the same as it was in the 1970s. "Soap, gloves, isolating patients, not reusing needles and quarantining the contacts of those who are ill - in theory it should be very easy to contain Ebola," says Piot.

    In practice though, other factors can make fighting an Ebola outbreak a difficult task. People who become ill and their families may be stigmatised by the community - resulting in a reluctance to come forward for help. Cultural beliefs lead some to think the disease is caused by witchcraft, while others are hostile towards health workers.

    "We shouldn't forget that this is a disease of poverty, of dysfunctional health systems - and of distrust," says Piot.

    For this reason, information, communication and involvement of community leaders are as important as the classical medical approach, he argues. Ebola changed Piot's life - following the discovery of the virus, he went on to research the Aids epidemic in Africa and became the founding executive director of the UNAIDS organisation.


    That is the story of dr. Piot., Thatis wonderful story and I would love to see such dedicated doc to get that Noble Prize......

    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #6 - October 08, 2014, 04:17 PM

    Thanks for sharing.
  • Science and Origins of Ebola viruses
     Reply #7 - October 08, 2014, 04:20 PM

    So what happens if the disease is eradicated in humans?...seems like it would bounce back
  • Science and Origins of Ebola viruses
     Reply #8 - October 08, 2014, 04:46 PM

    So what happens if the disease is eradicated in humans?...seems like it would bounce back

    well we will eradicate again .. we are not living in caves, we are not living in medieval times neither we are in 20 th century.. we are in 21st century... This time it may have killed some 2000 people .. next time if it flares up it will be 2 or 20 people .. any way the news says

    US Ebola patient Thomas Duncan dies in hospital


    Mr Duncan, shown here at a 2011 wedding in Ghana

    Quote
    The first person to be diagnosed with Ebola within the US has died, Texas hospital officials have said. Thomas Eric Duncan, who caught the virus in his native Liberia, was being kept in isolation in a Dallas hospital and receiving experimental drugs. Earlier the US announced new screening measures at entry points to check travellers for symptoms of the virus.

    More than 3,000 people have died and 7,500 infected, mostly in West Africa, in the worst Ebola outbreak yet. "It is with profound sadness and heartfelt disappointment that we must inform you of the death of Thomas Eric Duncan this morning at 7:51 am," a spokesman said in a statement.

    well that is the news..

    Ebola virus disease (EVD)




      
    Quote
    Symptoms

    include high fever, bleeding and central nervous system damage
        
    Spread by body fluids, such as blood and saliva
        
    Fatality rate can reach 90% - but current outbreak has mortality rate of about 70%
        
    Incubation period is two to 21 days
      
    There is no proven vaccine or cure
        
    Supportive care such as rehydrating patients who have diarrhoea and vomiting can help recovery
      
     Fruit bats, a delicacy for some West Africans, are considered to be virus's natural host


    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #9 - October 08, 2014, 05:12 PM

    ^Well that's not hopeful atall, was expecting him to recover like the other westerners who had specialist care.. :(
  • Science and Origins of Ebola viruses
     Reply #10 - October 08, 2014, 05:24 PM

    ^Well that's not hopeful atall, was expecting him to recover like the other westerners who had specialist care.. :(

    suki you are raising a very interesting point .... we will discuss that issue. but.. for now..

    Experimental drug the 'best choice' for American journalist with Ebola

    Quote
    An American journalist who contracted Ebola while working in Liberia is now being treated with an experimental drug, the same drug the first Ebola patient diagnosed in the U.S. is receiving. On Tuesday, Nebraska Medical Center announced Ashoka Mukpo, 33, is being treated with brincidofovir, made by biopharmaceutical company Chimerix.

    “After looking at the data on this drug, collaborating with the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) and speaking with the patient and his family, we decided this was currently our best option for treatment,” said Dr. Phil Smith, medical director of the Nebraska Medical Center’s Biocontainment Unit. “Every patient is somewhat different, and we believe brincidofovir is the best choice.”

    Quote
    Doctors are looking at other options for treatment as well. In a press conference Monday, freelance photographer Ashoka Mukpo’s parents said their son was in good spirits and that his condition— which included fever and some nausea— had not changed since he left Liberia. Mukpo is unsure of how he contracted the virus, but he thinks it may have occurred while he was spray washing something and contamination splashed back on him, his father, Dr. Mitchell Levy said.

    “I’ve asked him about it a lot, but he’s not certain,” Levy said.  Mukpo is being cared for by a team of 40 at Nebraska Medical Center.

    On Tuesday, a spokeswoman for Texas Health Presbyterian Hospital said the first Ebola patient diagnosed in the U.S., Thomas Eric Duncan, remains in critical condition and that his condition is stable. He is currently on a ventilator and receiving kidney dialysis. Doctors have seen improvement in his liver function, which declined over the weekend, but caution this could vary in coming days. He will continue to receive brincidofovir.

    Quote
    Duncan began receiving the experimental drug on Saturday afternoon, the hospital announced Monday. The drug, which comes in tablet form, is currently undergoing additional tests in laboratory animals infected with Ebola. According to a statement from Chimerix, it was approved by the FDA for use in human Ebola patients on Monday.

    Duncan, a Liberian man, arrived in Dallas on Sept. 20 and started to feel ill a few days later while visiting family. On Sunday, Dr. Thomas Frieden, director of the CDC, said he was aware that Duncan's health had "taken a turn for the worse," but he declined to describe Duncan's condition further. He was listed in critical but stable condition Monday.

    Quote
    Frieden told reporters on Sunday that Duncan was apparently not receiving experimental therapies, in part because there are no more doses of ZMapp, a cocktail of three antibodies.

    Asked about TKM-Ebola, the drug that Dr. Rick Sacra received in treatment when he was diagnosed with Ebola, Frieden said it "can be quite difficult for patients to take" and "can actually make someone sicker."

    Quote
    Neither supply nor administration is apparently an issue with brincidofovir, which was first developed to treat adenovirus infections in people with weakened immune systems.

    "Chimerix has brincidofovir tablets available for immediate use in clinical trials," the company said in a statement. It also said on Monday that the U.S. Food and Drug Administration approved its emergency use for Ebola patients and that it was working to set up clinical trials.


    TKM-Ebola is given intravenously. "IV access can be quite challenging with a medically compromised patient," Dr. Christopher Kratochvil, chief medical officer at UNeHealth, parent of the University of Nebraska Medical Center, said in an interview.

    Quote
    Shares in Chimerix rose 4.7 percent on Monday, and shares in TKM-Ebola manufacturer Tekmira fell nearly 19 percent.

    Another consideration in the choice of drugs for Duncan might have been safety. Ebola is infamous for causing massive fluid loss, which can lead to electrolyte imbalances that stress the heart and kidneys. Brincidofovir, also called CMX-001, has been tested in more than 1,000 patients without raising safety concerns, including kidney toxicity, the company said.


    Chimerix faced a firestorm of criticism this year when it initially declined to provide the drug on a "compassionate use" basis to 8-year-old Joshua Hardy, a Virginia boy who developed a potentially-fatal adenovirus infection after a bone marrow transplant for kidney cancer.

    The company relented and enrolled the boy in a clinical trial. He went home from the hospital in July, but the incident led Chimerix to replace its chief executive.

    CMX-001 is a compound called a nucleotide analog. Its molecules behave enough like those that form the genetic material (nucleotides) of viruses such as Ebola that the microbes incorporate it into their DNA or RNA, a sister molecule.

    But CMX-001 is different enough that, once incorporated, it prevent a virus's genetic material from replicating. That stops the virus from spreading throughout the body.

    When West Africa's Ebola outbreak was reported last March, Chimerix sent brincidofovir to government labs, including at the CDC and National Institutes of Health, to be tested against test-tube samples of the Ebola virus. It showed "potent activity," the company said.

    well Science and money making goes side by side.. It is better for every country to spend some money in their research & development .... and not depend on AMRIKA private companies all the time..

    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #11 - October 14, 2014, 03:35 PM

    The decades-old treatment that may save a young Dallas nurse infected with Ebola

    Quote
    The treatment, in fact, is nearly as old as the disease itself. Peter Piot of the London School of Hygiene and Tropical Medicine, who discovered Ebola in 1976 in Zaire, said the idea even back then was promising. “We had only one possible treatment option in the form of serum from convalescents who had very high levels of antibodies,” he explained to Science. The blood was later used to treat a researcher in the United Kingdom who infected himself while drawing blood from an Ebola-infected guinea pig. He survived.


    That is one heck of a funny news., I don't understand what these microbiologists doing all these years on this Ebola..

    well let me read this  http://jid.oxfordjournals.org/content/179/Supplement_1/S18.full.pdf

    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #12 - October 15, 2014, 06:39 PM

    Ebola: Everything You Need To Know In 94 Seconds

    https://www.youtube.com/watch?v=nfIJy5Ov52c


    Horizon Ebola virus The Search for a Cure
    https://www.youtube.com/watch?v=pRxC3kujbm4

    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • Science and Origins of Ebola viruses
     Reply #13 - October 23, 2014, 01:21 PM

    hmm   http://livecellresearch.com/livelonger-v18_2.php  interesting..

    so many ways to make money..........

    Quote
    Scientific Studies  Mitochondrial Function

    [1.] Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard BP, Mercken EM, Palmeira CM, de Cabo R, Rolo AP, Turner N, Bell EL, Sinclair DA. Cell. 2013 Dec 19;155(7):1624-38.

    [2.] NAD+ and sirtuins in aging and disease. Imai SI, Guarente L. Trends Cell Biol. 2014 Apr 28. pii: S0962-8924(14)00063-4.

    [3.] NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease. Cerutti R, Pirinen E, Lamperti C, Marchet S, Sauve AA, Li W, Leoni V, Schon EA, Dantzer F, Auwerx J, Viscomi C, Zeviani M. Cell Metab. 2014 May 7. pii: S1550-4131(14)00164-8.

    [4.] Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsström S, Pasila L, Velagapudi V, Carroll CJ, Auwerx J, Suomalainen A. EMBO Mol Med. 2014 Apr 6.

    [5.] The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cantó C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PJ, Yamamoto H, Andreux PA, Cettour-Rose P, Gademann K, Rinsch C, Schoonjans K, Sauve AA, Auwerx J. Cell Metab. 2012 Jun 6;15(6):838-47.
    Cognitive Function

    [1.] Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, Wang J, Sastre M, Ono K, Sauve AA, Pasinetti GM. Neurobiol Aging. 2013 Jun;34(6):1581-8.
    Neuropathies

    [1.] Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. Sasaki Y, Araki T, Milbrandt J. J Neurosci. 2006 Aug 16;26(33):8484-91.
    Myopathies

    [1.] NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy. Goody MF, Kelly MW, Reynolds CJ, Khalil A, Crawford BD, Henry CA. PLoS Biol. 2012;10(10):e1001409
    Metabolism

    [1.] Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Yoshino J, Mills KF, Yoon MJ, Imai S. Cell Metab. 2011 Oct 5;14(4):528-36.
    NAD+ Biosynthesis

    [1.] Assimilation of endogenous nicotinamide riboside is essential for calorie restriction-mediated life span extension in Saccharomyces cerevisiae. Lu SP, Kato M, Lin SJ. J Biol Chem. 2009 Jun 19;284(25):17110-9.

    [2.] Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism. Belenky P, Christensen KC, Gazzaniga F, Pletnev AA, Brenner C. J Biol Chem. 2009 Jan 2;284(1):158-64.

    [3.] Nicotinamide riboside kinase structures reveal new pathways to NAD+. Tempel W, Rabeh WM, Bogan KL, Belenky P, Wojcik M, Seidle HF, Nedyalkova L, Yang T, Sauve AA, Park HW, Brenner C. PLoS Biol. 2007 Oct 2;5(10):e263.

    [3.] Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD+. Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, Brenner C. Cell. 2007 May 4;129(3):473-84.

    [4.] Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Bieganowski P, Brenner C. Cell. 2004 May 14;117(4):495-502.

    [5.] The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cantó C, Mottis A, Jo YS, Viswanathan M, Schoonjans K, Guarente L, Auwerx J. Cell. 2013 Jul 18;154(2):430-41.

    [6.] NAD+ as a signaling molecule modulating metabolism. Cantó C, Auwerx J. Cold Spring Harb Symp Quant Biol. 2011;76:291-8.

    [7.] NAD⁺ metabolism: a therapeutic target for age-related metabolic disease.Mouchiroud L, Houtkooper RH, Auwerx J. Crit Rev Biochem Mol Biol. 2013 Jul-Aug;48(4):397-408.
    Reviews

    [1.] NAD+ and sirtuins in aging and disease. Imai SI, Guarente L. Trends Cell Biol. 2014 Apr 28. pii: S0962-8924(14)00063-4

    [2.] Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Chi Y, Sauve AA. Curr Opin Clin Nutr Metab Care. 2013 Nov;16(6):657-61

    [3.] Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Bogan KL, Brenner C. Annu Rev Nutr. 2008;28:115-30.

    [4.] NAD+ and vitamin B3: from metabolism to therapies. Sauve AA. J Pharmacol Exp Ther. 2008 Mar;324(3):883-93.

    [5.] NAD+ metabolism in health and disease. Belenky P, Bogan KL, Brenner C. Trends Biochem Sci. 2007 Jan;32(1):12-9. Epub 2006 Dec 11


    Well I ate LOT OF MITOCHONDRIA..    Cheesy Cheesy   and  this link http://www.scientificamerican.com/article/are-viruses-alive-2004/   has a good article to read and learn about viruses in general...

    Do not let silence become your legacy.. Question everything   
    I renounced my faith to become a kafir, 
    the beloved betrayed me and turned in to  a Muslim
     
  • 1« Previous thread | Next thread »